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Abstract
Background: Antimicrobial self-medication is common in most low and middle income countries (LMICs). However
there has been no systematic review on non-prescription antimicrobial use in these settings. This review thus intended
to establish the burden, risk factors and effects of antimicrobial self-medication in Low and Middle Income Countries.
Methods: In 2012, we registered a systematic review protocol in PROSPERO (CRD42012002508). We searched PubMed,
Medline, Scopus, and Embase databases using the following terms; “self-medication”, “non-prescription”, ‘self-treatment’,
“antimicrobial”, “antimalarial”, “antibiotic”, “antibacterial” “2002-2012” and combining them using Boolean operators.
We performed independent and duplicate screening and abstraction of study administrative data, prevalence,
determinants, type of antimicrobial agent, source, disease conditions, inappropriate use, drug adverse events and
clinical outcomes of antibiotic self-medication where possible. We performed a Random Effects Meta-analysis.
Results: A total of thirty four (34) studies involving 31,340 participants were included in the review. The overall
prevalence of antimicrobial self-medication was 38.8 % (95 % CI: 29.5-48.1). Most studies assessed non-prescription use
of antibacterial (17/34: 50 %) and antimalarial (5/34: 14.7 %) agents. The common disease symptoms managed were,
respiratory (50 %), fever (47 %) and gastrointestinal (45 %). The major sources of antimicrobials included, pharmacies
(65.5 %), leftover drugs (50 %) and drug shops (37.5 %). Twelve (12) studies reported inappropriate drug use; not
completing dose (6/12) and sharing of medicines (4/12). The main determinants of antimicrobial self-medication
include, level of education, age, gender, past successful use, severity of illness and income. Reported negative
outcomes of antimicrobial self-medication included, allergies (2/34: 5.9 %), lack of cure (4/34: 11.8 %) and causing death
(2/34: 5.9 %). The commonly reported positive outcome was recovery from illness (4/34: 11.8 %).
Conclusion: The prevalence of antimicrobial self-medication is high and varies in different communities as well as by
social determinants of health and is frequently associated with inappropriate drug use.
Background
Self-medication refers to the use of medicines to treat
self-diagnosed disorders without consulting a medical
practitioner and without any medical supervision [1]. It
is a common form of healthcare practiced in most parts
of the world, with over 50 % of antibiotics purchased
and used over-the-counter [2, 3]. Inadequacies in the
healthcare delivery systems especially in resource limited
countries such as inequitable distribution, high costs,
inaccessibility, lack of health care professionals, unregulated
distribution of medicines, patient attitudes towards physi-
cians are some of the key drivers of self-medication [4, 5].
Non-prescription use of antimicrobial drugs is associated
with the risk of inappropriate drug use which predisposes
patients to drug interactions, masking symptoms of under-
lying disease and development of microbial resistance [4,
6–8]. The inappropriate drug use practices common in
self-medication include; short duration of treatment, inad-
equate dose, sharing of medicines and stopping treatment
upon improvement of disease symptoms [9]. Resistance to
the available and affordable antimicrobial agents may fur-
ther reduce the already limited therapeutic choices in
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treatment of common infectious diseases in develop-
ing countries, increasing the risk of morbidity and
mortality [6].
In resource limited countries, the overall extent and de-
terminants of self-medication with antimicrobial agents is
difficult to quantify especially due to lack of monitoring
and record keeping [10]. In addition the findings of studies
on antimicrobial self-medication in these settings have not
been consistent for example, a study by Yousef et al.,
(2008) [5] reported self-medication to be influenced by the
high cost of health care, while lack of enforcement of leg-
islations restricting over-the-counter sale of antibiotics
was sighted as a reason for continued use of antimicrobial
self-medication [11]. In addition, a recent global anti-
microbial self-medication systematic review included few
studies from developing countries, and excluded antimal-
arial self-medication [3]. Although various individual stud-
ies have examined antimicrobial self-medication in low
and middle income countries, there has not been any sys-
tematic review done in this setting. There is need for evi-
dence from well-designed studies on community use of
antimicrobial drugs in these settings to help in planning
and implementation of specific interventions on non-
prescription antibiotic use.
We therefore performed a systematic review of obser-
vational studies to estimate the burden, risk factors and
effects of antimicrobial self-medication in communities
of low and middle income countries. Information on es-
timates of antimicrobial self-medication by geographical
regions, sources of drugs, sources of drug information,
clinical outcomes, antimicrobials agents and drug use
practices are also summarized.
Methods
Protocol development
In 2012, we developed and registered a review protocol
(#CRD42012002508) in the International Prospective
Register of Systematic Reviews that is available at: http://
www.crd.york.ac.uk/PROSPERO/. We observed the rec-
ommendations of the PRISMA statement [12] in devel-
oping this protocol and review conduct.
Search strategy
RS, a librarian with Infectious disease institute Makerere
University searched PubMed, Embase, Medline, and Sco-
pus databases to identify studies that investigated anti-
microbial self-medication in communities of low and
middle income countries. The following search terms
were combined using Boolean operators, antimicrobial,
antibiotics, antibacterial, antimalarial, self-medication,
non-prescription and the time period 2002-2012. Med-
ical Subject Headings (MeSH) of the search terms was
used in each case to maintain common terms across all
data bases searched. All database searches were updated
in February 2014. We searched bibliographies of in-
cluded studies for additional articles. There was no lan-
guage restrictions applied during the search neither did
we search any grey literature for additional articles.
Eligibility criteria for the articles included in the review
The review included studies on antimicrobial self-
medication among adult individuals (18 years or older)
in community households of low and middle income
countries. We included only studies which did not assess
chronic non-prescription antimicrobial use and reported
the estimate of its prevalence. We excluded studies that
assessed antimicrobial self-medication among; children,
pregnant/breast feeding mothers, institutionalized eld-
erly patients, students of health related courses and
health professionals. In addition editorials, letters to the
editor or comment publication type were also excluded.
Studies done on children below eighteen years and insti-
tutionalized elderly were excluded from the review as
they do not make independent treatment decisions;
while students and workers of health profession are
already exposed to unique knowledge and practices
about antimicrobial use. Additionally, we excluded sur-
veys of pharmacy bulk purchases or health facility exit
interviews. This is because they do not provide reliable
estimates of non-prescription antibiotic use despite be-
ing recommended by WHO for monitoring drug use [7].
We also excluded self-medication studies which mea-
sured knowledge only or attitude only or beliefs only
and did not determine community behavior or practices.
Studies on non-prescription antibiotic use done earlier
than 2002 were excluded from the review as they are
more likely to be affected by the regular changes in drug
polices and treatment guidelines.
Assessment of risk of bias of included studies
OC and EO independently assessed the risk of bias in
the included studies and any disparities were resolved by
discussion. We assessed the following potential sources
of bias in observational studies using a tool of eight cri-
teria that was adopted from the STROBE statement [13].
Selection bias due to sampling, selection bias due to re-
sponders or response rate (adequate if ≥ 60 %), detection
bias due to recall (≤1 month; [14], detection bias due;
social desirability, reliability of measurement tools and
method of analysis used to assess factors associated with
antimicrobial self-medication. We contacted authors of
the included articles for clarification where information
was missing. Each of the risk of bias criteria was
assessed as low (scored as 0), moderate/high or unclear
(scored as 1). We manually computed these scores into
three levels of bias with 0-2 (low risk), 3-4 (moderate
risk) and 5-8 (high risk).
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Data abstraction
We developed a data abstraction spreadsheet using
Excel version 2007 (Microsoft Corporation, Redmond,
Washington, USA). OC and EO conducted duplicate and
independent abstraction of data from the included studies.
We captured the following information, author, year of
publication, journal, country where the study was done, re-
call period, study design, sample size, response rate, preva-
lence of antimicrobial self-medication, type of antimicrobial
agents used, source of drugs, source of drug information,
disease symptoms, determinants of antimicrobial self-
medication, adverse effects, disease symptom resolution,
risks associated with antimicrobial self-medication,
reasons for self-medication, duration of drug use, and
inappropriate drug use practices (not completing dose,
sharing of drugs and short duration of use). In order to as-
sess the determinants of antimicrobial self–medication, we
considered data from only those studies that conducted
multivariable regression.
Data synthesis
We exported the Excel© abstraction sheet to Stata© soft-
ware version 12.0 (Stata Corp, College Station, Texas,
USA) for analysis. We performed both structured narra-
tive and quantitative syntheses as appropriate. In the
structured synthesis we generated descriptive summaries
of the outcomes of interest from the included studies for
the sources of drugs and drug information, types of anti-
microbials, reported clinical outcomes, drug use prac-
tices and the determinants of self–medication. In order
to estimate the prevalence of antimicrobial self–medica-
tion, we recomputed the primary study measures of pro-
portions and the corresponding standard errors taking
into regard the response rate.
We performed a DerSimonian–Laird Random Effects
Meta–analysis to estimate the summary measure of the
prevalence of antimicrobial self–medication, using the
Stata© command “metaan”. We displayed our findings in
a forest plot and explored the high heterogeneity using
the following sub – group analyses; region where the
study was conducted (sub-Saharan Africa, Latin Amer-
ica, Middle East and Asia) as well as the levels of risk of
bias (low, moderate and high) as shown in Table 2.
Results
Study selection
The search of PubMed, Embase, Medline and Scopus
data bases provided a total of 4,400 citations. After
adjusting for duplicates 3,572 citations remained. Of
these 3,401 studies were discarded since after reviewing
their titles and abstracts, they did not meet the criteria.
Seven studies were discarded as their full text was not
available. The full text of the remaining 171 studies was
reviewed in detail. A total of 143 studies did not meet
the criteria and were discarded. Thirty four (34) studies
met the inclusion criteria and were included in the sys-
tematic review. Additional six studies that met the cri-
teria for inclusion were identified through searching the
reference lists of located, relevant papers and searching
for the studies that had cited these papers (Fig. 1). Two
reviewers OM and EO screened the studies for inclusion
and exclusion in the review with a kappa agreement of
0.74 (74 %).
Characteristics of included studies
All the thirty four (34) studies finally selected for the re-
view were cross-sectional observational studies pub-
lished in English, French and Spanish and involved
31,340 participants. The recall period used in data col-
lection varied among different studies, ranging from two
weeks to one year (12 months). Most studies (19/34:
55.9 %) reported recall period used in data collection. Of
the included studies, seven (7/34: 20.6 %) used a time
lag of between two -to- four weeks [15–21] (Table 1).
While three studies (3/34: 8.8 %) used twelve months
[22–24].
Of the 34 studies, only 7 (20.6 %) established determi-
nants of antimicrobial self-medication using multiple re-
gression analysis. Fifteen studies (15) were from Sub-
Saharan Africa, eight (08) Asia, eight (08) Middle East
and three (3) from South America. Nineteen (19) studies
reported the recall period used during data collection.
Less than one month [15–21], 2-5 months [25–29] and
6-12 months [22–24, 30–33] while fifteen studies did
not report the recall period use [34–48] (Table 1).
The majority of studies, 79.1 % (27/34) reported symp-
toms related to infections of; respiratory tract, gastro-
intestinal system, eye, ear, urinary system, skin and
malaria as the reason for self-medication. Of the thirty
four (34) studies, five (5) reported the duration of treat-
ment using antimicrobial self-medication in manage-
ment of the illness. Four-to-seven days [21] (antibiotics);
one-to-three days [32] (antimalarial); three days [23]
(antimalarial); and three-four days [16, 17] (antibiotics).
Risk of bias in the included studies
The majority of included studies (27/34: 79.4 %) did not
assess determinants of antimicrobial self-medication
using multivariable regression analysis. Fourteen of the
included studies (14/34: 41.1 %) had low risk of bias,
twelve (12/34: 35.3 %) had moderate risk of bias while
eight (8/34: 23.5 %) had a high risk of bias.
Following the risk of bias assessment criteria used,
most of the included studies had potential risk of; bias
due to method of analysis used in establishing associated
factors (28/34: 82.4 %), recall bias (23/30: 67.6 %), selec-
tion bias (12/34: 35.3 %), detection bias due to social de-
sirability (13/34: 38.2 %), selection bias due to baseline
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characteristics (17/34: 50 %) and selection bias due to
sampling criteria (13/34: 38.2 %) (Additional file 1:
Appendix 1).
Antimicrobial medicines commonly used in self-medication
The major categories of antimicrobial agents reportedly
used in self-medication included antimalarial and antibac-
terial. Of the thirty four studies included in the review,
seventeen (50 %) investigated only antibacterial drugs,
eight (23.5 %) antibacterial and antimalarial drugs, five
(14.7 %) antimalarial drugs only, and four (11.8 %) studied
multiple antimicrobial agents used in self-medication. The
antimalarial medicines commonly used in self-medication
included, chloroquine, sulfadoxine-pyrimethamine, halo-
fantrine, Artemether-Lumefantrine, and quinine. While
the antibacterial agents used included; ampicillin, tetracyc-
line, penicillin, metronidazole, ceftriaxone, kanamycin,
ciprofloxacin, amoxicillin, fradiomisin-gramisidin, norflox-
acin and doxycycline (Table 2).
Source of medicines, information and benefits of
antibiotic self-medication
Information on antimicrobial agents used in self-
medication in developing countries is obtained from vari-
ous sources. Majority of the studies reported drug sellers
or pharmacists and relatives or friends. The other reported
sources include; past successful use and drug leaflets. The
antimicrobial drugs used in self-medication were obtained
from various sources such as pharmacies, leftover drugs,
hospitals, gifts from friends and drug shops.
The antimicrobial agents used in self-medication were
obtained from various sources such as pharmacies, 61.8 %
(21/34); leftover drugs, 41.2 % (14/34); gifts from friends/
relatives, 26.5 % (9/34), drug shops, 23.5 % (8/34) and
health facilities, 26.5 % (9/34).
The reported importance of antimicrobial self-
medication include, saving time [19, 25, 32, 35, 41–43,
45, 46], avoids crowding [23], and quick relief of the
illness [35].
Prevalence of antimicrobial self-medication
The prevalence of antimicrobial self-medication in low
and middle income countries varied widely with some
studies reporting as low as 4.0 % in Yemen [34] to as high
as 91.4 % in Nigeria [46]. The overall estimate of anti-
microbial self-medication in low and middle income coun-
tries is 38.8 % (95 % CI: 29.5-48.1). Reports from studies
done in South America had a high, 44.1 % % (95 % CI:
9.7 %-78.6 %) overall prevalence of antimicrobial self-




























Records from database searches (n= 4,400)
(PubMed 906, EMBASE 1,057, MEDLINE 184, SCOPUS 2253)
Titles and abstracts 
screened 
(n =3,572)
Excluded studies (n =3,401) 
- Totally irrelevant (n=2,712)
- Alternative Medicine (n=80)
- Children and Adolescents (n=40)
- Editorials (n=136)
- Elderly, Travelers (n= 15)
- Health Care Workers/Students (n=35)
- Health Facility/Community Pharmacy (n=19)
- Full texts not retrievable (n=26)
- Not LMICs (n=53)
- Only knowledge, attitude & perception (n=07)
- Other drugs, non-drug interventions, chronic 
disease conditions (n=275)
- Qualitative studies (n=03)
Full text articles retrieved 
(n= 171 + 6 = 177)




Excluded full text articles (n=143)
- Totally irrelevant (n=09)
- Alternative Medicine (n=02)
- Children and Adolescents (n=05)
- Elderly, Travelers (n=03)
- Health Care Workers/Students (n=26)
- Health Facility/Community Pharmacy (n=24)
- Not LMICs (n=16)
- KAP only (n=02)
- Other drugs, non-drug interventions, chronic 
disease conditions (n=13)
- General self-medication (n=41)
- Qualitative studies (n=02)
Fig. 1 Flow diagram of study selection
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of SM ( %)
Incorrect drug use Outcomes Disease symptoms treated
Abdo-Rabbo,
2003
Yemen NR 4 % NR NR Fever (4 %)
Agbor (2011) Cameroon NR 21.2 % Symptoms resolved
in a week (39.7 %)
Tooth ache (54.7 %), gingival
bleeding (13 %)
Al-Azzam, 2007 Jordan 4 9.5 % NR NR RTIs (39.1 %), GIT (4.9 %), UTIs
(2.9 %), Ear (1.3 %)
Askarian, 2012 Iran 52 43.7 % NR NR RTIs (73.1 %, GIT (41 %)
Auta, 2012 Nigeria 3 17.9 % NR NR NR
Awad, 2005 Sudan 4 73.7 % Inadequate dose (39 %),
Short duration (39 %)
NR RTIs (20.1 %), fever/malaria (5.5 %)
Bano, 2012 Pakistan NR 55 % Wrong dose, short duration NR RTIs (41.3 %), fever/malaria (80 %),
GIT (61.3 %), Skin (72.6 %)
Barah, 2010 Syria 4 48.4 % Stop taking drugs when
symptoms improve (50 %)
Allergies (13 %), failed
to cure (10 %)
NR
Chowdhury, 2009 Bangladesh 24 18.3 % Stopped taking drugs when
felt better (3.6 %)
Symptoms resolved
(2.2 %)
Fever/malaria (55 %), GIT (9 %),
Skin (11 %)
de Oliveira, 2004 Brazil NR 10.1 % Incorrect use (0.5 %) Symptoms did not
resolve (3.5 %)
NR
Deressa, 2003 Ethiopia 24 17.8 % Dose not completed (4.3 %) NR Fever/malaria (97 %)
Enato, 2011 Nigeria 2 44.9 % NR Symptoms resolved
(96 %)
Fever/malaria (57.6 %)
Hussain, 2011 Pakistan 12 17.8 % NR NR RTIs (14.5 %), fever/malaria (57.6 %),
GIT (8.4 %), Skin (8.6 %)
Jassim, 2010 Iraq NR 63.5 % Dose not completed (54 %),
sharing drugs (12 %)
NR RTIs (11.3 %), fever/malaria (8.1 %),
GIT (11.3 %), Skin (4.9 %), UTIs
(4.1 %), Ear (3.6 %)
Jombo, 2011 W. Africa NR 38.4 % NR NR NR
Lima, 2010 Brazil NR 69.2 % Sharing drugs NR RTIs, GIT
Mossa, 2012 Ethiopia 12 14.6 % NR NR RTIs (14.1 %), fever/malaria (35.9 %),
GIT (10.2 %)
Nounon, 2009 Argentina NR 53.1 % Stopped taking drugs when
felt better (14 %)
Symptoms resolved
(4 %)
RTIs (48 %), fever/malaria (18 %),
Skin (1 %), UTIs (7 %)
Ngasha, 2011 Cameroon NR 55.7 % NR Symptoms did not
resolve
Fever/malaria
Okumura, 2002 Vietnam NR 12.7 % NR NR RTIs (3.1 %), GIT (1.6 %)
Onanuga, 2011 Nigeria NR 45 % Not completed dose (16.7 %),
stopped taking drugs when






Nigeria NR 54.8 % NR NR Fever/malaria (49.6 %)
Osemene, 2012 Nigeria NR 91.4 % NR NR RTIs (15.3 %), fever/malaria (5.5 %),
GIT (10.2 %), UTIs (43.5 %), Ear (2 %)
Oyetunde, 2010 Nigeria NR 25.9 % Short duration (90 %) NR NR
Omole, 2010 Nigeria 12 35.7 % NR Not cured (33.7 %),
cured (12.9 %)
Fever/malaria, GIT
Sanjana, 2006 Indonesia 52 42 % NR Adverse effects (23 %),
relapse of malaria
Fever/malaria (93 %), GIT (17 %)
Sapkota, 2010 Nigeria 12 25.2 % NR NR None specific symptoms
Sarahroodi, 2009 Iran 12 54.5 % Not completing dose (74.2 %) NR RTIs (66.7 %), GIT (23 %)
Sawalha, 2008 Palestine 24 19.4 % Not completing dose (59.9 %) NR RTIs (30.3 %), Ear (3.3 %)
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(95 % CI: 23.4 %-44.9 %) (Table 3). The overall prevalence
was higher among respondents who reported using
multiple medicines, 61.9 % (95 % CI: 53.9 %-70.1 %),
both antibacterial and antimalarial agents, 42.9 % (95 %
CI: 19.6 %-66.3 %), antibacterial agents 33.4 % (95 % CI:
20.6 %-46.1 %) and lower in studies in which partici-
pants used only antimalarial agents only 30.3 % (95 % CI:
10.1 %-50.4 %). There was high heterogeneity in the
included studies (I2 = 100 %) for all the sub-groups
(geographic region, risk of bias, medicine used) assessed.
Inappropriate practices of antimicrobial drug use in
self-medication
The most common inappropriate practice in non-
prescription use of antimicrobial agents include: short
duration of treatment mostly less than five days [16, 17,
32, 44, 47], insufficient dose of medication [17, 19, 32,
47], wrong indication (use of antibacterial drugs in treat-
ing viral infections) [17, 22], and exchange/sharing of
medicines [38, 40, 48, 49].
The use of antibacterial drugs in treating viral infections
was mostly reported in studies done in the Middle East
[22] and Asia [17]. The agents commonly used in treating
symptoms of viral infections such as flu included; ampicil-
lin, tetracycline, metronidazole, ceftriaxone, kanamycin,
cotrimoxazole [17, 22]. Short duration of treatment (<5days)
using antimicrobial self-medication was commonly reported
in Asian studies, [16, 17]. Insufficient dose of medications
used in self-medication was mostly reported in sub-Saharan
African studies [19, 32] and Asia [17].
Factors associated with antimicrobial self-medication in
developing countries
The commonly reported factors that determined anti-
microbial self-medication included; past successful use
[33], low level of education [19, 21, 26, 33, 46], female
gender [33], age [21, 33] and middle income [19, 21, 26,
33, 46]. Studies done in Africa reported; low level of
education, severity of illness (mild-to-severe), female
gender, age (≥45 years) and middle income as determi-
nants of antimicrobial self-medication. Similarly in the
Middle East, level of education, age (18-39 years) and
middle income (Table 4).
Clinical outcomes of antimicrobial self-medication
The studies included in the review reported both posi-
tive and negative outcomes of the use of antimicrobial
self-medication. The negative outcomes included; aller-
gies [18, 22], lack of cure [23, 28, 37, 44] and causing
death [22, 43]. While positive outcomes attributed to the
use of antimicrobial self-medication included recovery
from the illness [15, 28, 33, 35].
Duration of use of antimicrobial drugs in self-medication
Twenty nine (29/34: 85.3 %) of the included studies did
not report the duration which participants spent using
antibiotics during an illness episode. In a study by Al-
Azzam, 2007 [21], participants spent 4-7 days taking
non-prescription antibacterial drugs during an illness. In
studies by Deressa, 2003 and Sanjana, 2006 [23, 32]
participants spent 1-3 days taking antimalarial drugs
Table 1 Summary of included studies on antimicrobial self-medication in LMICs (Continued)
Shankar, 2002 Nepal 24 59.2 % NR NR Fever/malaria
Shehadeh, 2012 Jordan 52 30 % Not completing dose (38.5 %) ADRs (69.6 %), Allergy,
harm the teeth
RTIs (31 %), UTIs (4.7 %), Ear (3.8 %)
Sihavong, 2006 LPR 52 91 % Short duration of taking
drugs (79 %)
NR UTIs (78 %)
Widayati, 2011 Indonesia 4 8.1 % Short duration of taking
drugs (36.6 %)
NR RTIs (31.8 %), fever/malaria (12.2 %)
Yousif, 2002 Sudan NR 46.9 % Sharing drugs (59.3 %), Not
completing dose (28.8 %)
NR NR
LMICs: Low and Middle Income countries, NR: Not Reported, RTIs: Respiratory Tract Infections, GIT: Gastrointestinal tract, UTIs: Urinary Tract Infections, LPR: Lao
People’s Republic
Table 2 Characteristics of antimicrobial drugs used in self-medication
Type of
antimicrobial
Class of antimicrobial Drug source Source of information
Antibacterial B-lactam, Tetracycline, fluoroquinolone, macrolide,
quinolone, aminoglycoside, others
leftover, pharmacy, drug shop,
friends/relatives
drug seller, self, drug leaflet, past
prescription, friends
Antimalarial Artemisinins, 4-aminoquinolines, 8-aminoquinlines
Cinchona alkaloid Sulfonamides/sulfone Diaminopyrimidine
pharmacy, leftover, friends/relatives past prescriptions, self, drug seller,
friends
Antifungal Azoles pharmacy, leftover drug seller, self
Anthelmintic Imidazole pharmacy, leftover drug seller, self, past prescription,
friends
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(Sulphadoxine-Pyrimethamine, chloroquine). Other stud-
ies [16, 17], reported participants spending less than five




Community drug sellers often do not have adequate bio-
medical knowledge of the antimicrobial agents and the
disease processes. However they are commonly used as
source of advice or information for the antimicrobial
agents obtained and used over-the-counter. Settings in
which individuals are highly educated tend to have rela-
tively low levels of use of antimicrobial self-medication.
Therefore promotion of literacy among communities is
an important target to minimize antimicrobial self-
medication in LMICs. Due to their prior successful use
of antimicrobial agents, individuals in most communities
tend to believe that they are able to manage subsequent
illness without consulting a physician. This is a potential
risk factor for inappropriate drug use since most patients
lack knowledge of the disease process and the medicines
used in self-medication. In the review, adverse effects of
antimicrobial self-medication were rarely reported in the
articles from most studies in LMICs.
Responsible self-medication has the potential of being
an important alternative to the formal healthcare system,
providing patients the opportunity of accessing immediate
healthcare [50]. However in most communities especially
of developing countries, in addition to accessing medicines
designated as over-the-counter, individuals also use pre-
scription only medicines without any medical supervision.
Such a practice is not likely to benefit patients especially
in the case of antibiotics as it’s associated with potential
risks to both the patient and community. The reason (s)
why individuals decide to use medicines designated as pre-
scription only without any guidance from a health profes-
sional are unique to different settings and are reflective of
Table 3 Pooled results for the prevalence of self-medication by region, antibiotic used and condition treated
Category Description Number of studies(n = 34) Number of respondents Prevalence of SM 95 % CI
Geographic region Sub-Saharan Africa 15 11667 40.6 % 25.8–55.8
Asia 8 6980 38 % 15.2.60.8
Middle East 8 11942 34.1 % 23.4–44.8
South America 3 751 44.1 % 9.7–78.6
Risk of bias Low 14 25009 39.2 % 21.6–56.9
Moderate 12 3331 39.1 % 31.2–46.9
High 8 1131 37.6 % 22.3–52.8
Medicine used Antibacterial only 17 8486 33.4 % 20.6–46.1
Antimalarial only 5 2411 30.3 % 10.1–50.4
Antibacterial and Antimalarial 8 10818 42.9 % 19.6–66.8
Multiple antimicrobial agents 4 735 61.9 % 53.9–70.1
SM: Self–medication, %: Percentage, CI: Confidence Interval







Determinants of antimicrobial Self-medication
Africa 3/15 Sapkota, 2010 706 Lower lever of education (OR: 2.8, 95 % CI: 1.1-7.1, P = 0.03)
Non-science qualification (OR: 1.58, 95 % CI: 1.03-2.2.5, P = 0.04)
Severity of illness (mild to moderate) (OR: 1.64, 95 % CI: 1.01-2.67, P = 0.05)
Osemene, 2012 2000 Age (≥ 45 years) (OR: 3.4, P = 0.001)
Female gender (OR: 3.8, P = 0.001)
Awad, 2005 1750 Female gender (OR: 1.8, 95 % CI: 1.4-2.4
aAsia 0/8 None None None
Middle East 1/8 Al-Azzam, 2007 8864 Age (18-39 years) (OR: 1.59, 95 % CI: 1.3-1.95, P < 0.05)
Education (primary) (OR: 2.1, 95 % CI: 1.09-2.08, P < 0.013)
Income status (middle) (OR: 1.48, 95 % CI: 1.18-1.85, P = 0.001)
aS. America 0/3 None None None
aNo single study done in South America or Asia performed multivariable regression analysis to establish determinants of antimicrobial self-medication
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a matrix of health system, societal, economic and health
factors [11]. Therefore establishing these factors is a crit-
ical step in designing and implementation of interventions
against irresponsible self-medication. The current review
also presents estimate of the prevalence of antibiotic self-
medication and the associated clinical outcomes in com-
munities of LMICs.
In this review, the prevalence of antimicrobial self-
medication in LMICs was 38.8 % and is consistent with
the findings (39 %) of a previous review on global anti-
microbial self-medication [3]. The use of antibiotics
without a prescription occurs globally despite their pre-
scription only legal status in most countries [3]. Our re-
view revealed that the prevalence of non-prescription
antibiotic use in LMICs is similar to the global rate.
However the high levels of poverty as individuals cannot
afford full antibiotic course and illiteracy potentially in-
crease the likelihood of risks associated with non-
prescription antibiotic use in LMICs [19]. For example
development of antibiotic resistance, a consequence of
inappropriate drug use commonly associated with self-
medication causes higher mortality in LMICs compared
to the developed nations [51]. Our review also showed
that the prevalence of antibiotic self-medication varied
in different regions. This could be due to the difference
in the effectiveness of enforcement of regulations on
antibiotic self-medication in different resource limited
countries. However, there was significant heterogeneity
in the outcome of studies included in the review even
after we performed sub-group analysis (region and risk
of bias). Therefore we could not combine the included
studies in a meta-analysis.
Self-medication has potential benefits which are shared
among patients, healthcare professionals, healthcare sys-
tem, and the pharmaceutical industry. For the industry; in-
creased access to the products results in more profits;
health professionals avoid unnecessary consultations with
patients having minor symptoms; healthcare costs to gov-
ernment are reduced as individuals meet their healthcare
bills and patients gain greater empowerment thus improv-
ing patient-clinician relationship [10]. A study included in
this review reported rapid resolution of disease symptoms
among participants [52]. Others showed that using anti-
microbial self-medication, saves time, is affordable, and
convenient. These positive attributes of self-medication,
further reinforce community use of antimicrobial self-
medication in management of prevalent illnesses.
However, it should be noted that the potential benefits
associated with self-medication will only be achieved if
it’s done responsibly and the medicines used are safe,
efficacious and information leading to their safe use is
easily accessible to the communities [11].
The underlying challenges of health systems in most
LMICs such as inadequate healthcare potentially influence
use of self-medication [11]. In addition, the lack of policies
or their inadequate implementation enables easy over-the-
counter access of antibiotics [53]. A previous study in
northern Uganda found that over half (59.3 %) of commu-
nity members who practiced antimicrobial self-medication
were not aware of any restrictions on their non-
prescription use in the country [54]. This occurs in spite
of the existence of national drug policy formulated in 2002
which limits antibiotics to prescription only use. Further-
more, most LMICs face the challenge of irregular supply
of drugs to the public health facilities which limits com-
munity access to healthcare. This coupled with the high
burden of infectious diseases in these countries makes the
private sector an important alternative source of health-
care [6]. However, the profit oriented nature of service
delivery in this sector in addition to the inadequate
supervision, influence over-the-counter sale of antibi-
otics despite their prescription only legal status. The
question facing most LMICs who suffer high burden of
infectious diseases is how to balance improved access
to antibiotics for individuals with true infectious dis-
eases through self-medication while at the same time
ensuring appropriate use.
The key determinants of antimicrobial self-medication
in LMICs included; severity of illness, economic status,
past successful use and educational level. Most community
members do not visit a health professional prior to initiat-
ing treatment due to the associated costs such as time,
travel expenses and consultation charges [55]. The high
level of poverty in communities of most LMICs in addition
to the fact that patients can purchase antibiotics over-the-
counter using any amount of money influence antibiotic
use practices [11]. The prevalent belief in self-efficacy
among patients due to past illness experiences further im-
pacts on the use of antibiotic self-medication. Community
members with a high level of education were more likely
to use antimicrobial self-medicate possibly due to the ex-
posure and increased awareness on health [56]. Patients
who assessed the symptoms of their illnesses as mild or
moderate were more likely not to consult a healthcare pro-
fessional. However, lack of biomedical knowledge of the
disease symptoms is likely to increase the risk of inappro-
priate antibiotic use practices such as stopping treatment
when symptoms resolve [11], delay in seeking appropriate
treatment which may potentially result in more severe dis-
ease. Delay in seeking medical care has been associated
with increased mortality among patients suffering from
treatable infections such as malaria [57]. The decision by
individuals in communities to use self-medication is as a
result of complex interaction of various factors such as
quality of healthcare, regulatory environment, burden of
disease, economic factors and belief [11]. Therefore inter-
ventions to mitigate antibiotic self-medication especially in
LMICs need to specifically focus on these primary factors.
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The review established inappropriate practices in anti-
biotic self-medication in communities of LMICs. These
included, not completing dose, sharing drugs, stopping
use of drugs when symptoms improve and inaccurate in-
dication. The use of antibacterial agents in treatment of
common cold was reported in studies done in Jordan
[21], Iran [24], Palestine [30], Vietnam [43], and Sudan
[19]. Not completing the dose of antibiotics carries a risk
of clinical failure. Previous studies done in children with
mild pneumonia using 3 day and 5 day amoxicillin found
non-compliance as the main reason for treatment failure
[58, 59]. The majority of studies included in the review
reported self-medication using multiple antimicrobial
agents. The use of more than one antibiotic during an
illness episode is indicative of the uncertainty of the
cause of illness. These inappropriate practices potentially
increase the risk of mistreatment, adverse drug reactions,
resistance development and drug interactions [6, 7, 10].
This is further worsened by the high burden of infectious
diseases in addition to the limited therapeutic choices in
most LMICs [6]. Antibiotic resistance is likely to add fur-
ther financial strain to the healthcare system which is
already faced with the challenge of inadequate funding.
This is especially the case as patients with resistant infec-
tions are likely to stay longer in hospitals and the need to
use more expensive second line antibiotic drugs. Agencies
such as World Health Organization (WHO), World Self-
medication Industry (WSMI) and the ministries of health
of LMICs need to establish specific interventions focusing
on these common inappropriate antibiotic use practices.
The review found that drug sellers, previous successful
use, drug leaflets, past prescriptions and friends or rela-
tives were the main sources of drug information in self-
medication. Drug leaflets are an important source of in-
formation, however poor readability makes using them
challenging to use [6]. In addition, the high level of
illiteracy in LMICs further limits the effectiveness of
leaflets as a source of information. Providing this infor-
mation in indigenous languages in addition to well writ-
ten information could improve the usefulness of drug
leaflets in these settings [6]. Prescription practices of
physicians in communities are likely to influence anti-
biotic use behavior of the local population as patients
commonly refer to old prescriptions in choosing medi-
cines used in self-medication [11]. Interventions such as
retention of prescriptions in the pharmacy could help
mitigate use of old prescriptions in making treatment
decisions in communities [60]. Drug sellers in most of
the developing countries have less impetuous of knowing
biomedical information of the drugs they sell as they as-
sume that patients know what they want and for them
they know the price [50]. In Lao People’s Republic, over
half (59 %) of drug dispensers are not knowledgeable
about the drugs that they were selling [61]. However, in
this review drug sellers were frequently reported as a
source of information for antibiotics obtained over-the-
counter despite their potential lack of biomedical
knowledge of these drugs. This increases the risk of misin-
forming their clients on the antibiotic agents accessed
over-the-counter. Non-prescription use of antibiotics with-
out relevant information on how to take them, indications,
adverse effects and contraindications could potentially ex-
pose patients to the risk of inappropriate drug use [62].
Health personnel in communities of LMICs are thus an
important target for sensitization, monitoring and support
supervision.
The review had some limitations, variation in the tech-
niques of data collection and reporting in the primary
studies which were included. There was a potential of
bias in the included studies due to; method of analysis,
recall, selection and social desirability. This invariably
has an effect on the findings of the primary studies. For
example, majority of studies used recall period of more
than six months while others did not report the duration
of recall used during data collection. In a previous study
[63], it was found that a recall period of more than one
month was significantly associated with the risk of recall
bias. The use of non-random methods in participant re-
cruitment in addition to not validating the data collec-
tion tools was common in most surveys and could
potentially have an effect on the study outcomes. There
was high heterogeneity in the studies reviewed possibly
due to lack of standardized criteria of survey data collec-
tion. We were unable to access some articles during the
study selection in spite of all the efforts taken. The stud-
ies included in the review rarely reported on the negative
outcomes of antibiotic self-medication experienced by
community members. This could be due to limited
knowledge of the antibiotic medicines that they used in
self-medication [34].
Conclusions
Antimicrobial self-medication is highly prevalent in re-
source limited countries and is commonly associated with
inappropriate use. Although self-medication is an import-
ant alternative to the formal health sector especially in
most LMICs, it is imperative that decisions to use non-
prescription antimicrobial agents are both safe and appro-
priate if the potential benefits are to be maximized with
minimal risks. Educational interventions targeting both
health personnel and community members in addition to
improving access to quality of public healthcare, enforce-
ment of regulations on non-prescription medicine use,
and reducing the burden of infectious diseases could help
mitigate the challenge of non-prescription antibiotic use
in LMICs. The practice of referring to old prescriptions
and past successful treatment experiences by the commu-
nities is key areas of focus for the interventions. There is
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an urgent need to development and validate a method for
collecting data on community antimicrobial use to help
improve the quality of evidence from such survey studies.
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